Context Therapeutics Inc (CNTX)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | SMITH, KAREN L. | Director | Stock Option (right to buy) | Acquisition | 45,000 | 0 |
| Jun 24, 2026 | WEST, LINDA | Director | Stock Option (right to buy) | Acquisition | 45,000 | 0 |
| Jun 24, 2026 | PASTERNAK, ANDY | Director | Stock Option (right to buy) | Acquisition | 45,000 | 0 |
| Jun 24, 2026 | WALKER, LUKE NATHANIEL | Director | Stock Option (right to buy) | Acquisition | 45,000 | 0 |
| Jun 24, 2026 | KANTOFF, PHILIP W. | Director | Stock Option (right to buy) | Acquisition | 45,000 | 0 |
| Jun 24, 2026 | STACEY, JENNIFER EVANS | Director | Stock Option (right to buy) | Acquisition | 45,000 | 0 |
| Feb 19, 2026 | MINAI-AZARY, JENNIFER LYNN | Chief Financial Officer | Stock Option (right to buy) | Acquisition | 275,000 | 0 |
| Feb 19, 2026 | CHAGIN, KAREN DEBORAH | Chief Medical Officer | Stock Option (right to buy) | Acquisition | 290,000 | 0 |
| Feb 19, 2026 | LEVIT, ALEX C. | Chief Legal Officer, Corp. Sec | Stock Option (right to buy) | Acquisition | 270,000 | 0 |
| Feb 19, 2026 | LEHR, MARTIN A. | Director, Chief Executive Officer | Stock Option (right to buy) | Acquisition | 815,000 | 0 |